Meningococcal group A, C, Y and W-135 conjugate vaccine

被引：17
|
作者：
Harrison, Lee H. [1 ,2 ]
Mohan, Nitin [3 ]
Kirkpatrick, Peter
机构：
[1] Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Grad Sch Publ Hlth, Pittsburgh, PA 15101 USA
[2] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15101 USA
[3] IMS Hlth Amer, Toronto, ON, Canada
来源：
NATURE REVIEWS DRUG DISCOVERY | 2010年 / 9卷 / 06期
关键词：
GLYCOCONJUGATE VACCINE; IMMUNOGENICITY;
D O I：
10.1038/nrd3194
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people aged 11–55 years.
引用
收藏
页码：429 / 430
页数：2
相关论文
共 50 条
  • [1] Meningococcal group A, C, Y and W-135 conjugate vaccine
    Lee H. Harrison
    Nitin Mohan
    Peter Kirkpatrick
    [J]. Nature Reviews Drug Discovery, 2010, 9 : 429 - 430
  • [2] Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
    Hedari, Carine P.
    Khinkarly, Rima W.
    Dbaibo, Ghassan S.
    [J]. INFECTION AND DRUG RESISTANCE, 2014, 7 : 85 - 99
  • [3] Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines
    Pace, David
    Pollard, Andrew J.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (10) : 909 - 915
  • [4] Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
    Bermal, Nancy
    Huang, Li-Min
    Dubey, A. P.
    Jain, Hermant
    Bavdekar, Ashish
    Lin, Tzou-Yien
    Bianco, Veronique
    Baine, Yaela
    Miller, Jacqueline M.
    [J]. HUMAN VACCINES, 2011, 7 (02): : 239 - 247
  • [5] Meningococcal A, C, W135 and Y conjugate vaccine
    不详
    [J]. AUSTRALIAN PRESCRIBER, 2011, 34 (01) : 30 - 30
  • [6] TETRAVALENT (A, C, Y, W-135) MENINGOCOCCAL VACCINE IN CHILDREN - IMMUNOGENICITY AND SAFETY
    CADOZ, M
    ARMAND, J
    ARMINJON, F
    GIRE, R
    LAFAIX, C
    [J]. VACCINE, 1985, 3 (03) : 340 - 342
  • [7] ost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents
    Si, Si
    Zomer, Ella
    Fletcher, Samantha
    Lee, Jenny
    Liew, Danny
    [J]. VACCINE, 2019, 37 (35) : 5009 - 5015
  • [8] Menveo®: a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y
    Cooper, Brian
    DeTora, Lisa
    Stoddard, Jeffrey
    [J]. EXPERT REVIEW OF VACCINES, 2011, 10 (01) : 21 - 33
  • [9] Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135
    Keyserling, Harry L.
    Pollard, Andrew J.
    DeTora, Lisa M.
    Gilmet, Gregory P.
    [J]. EXPERT REVIEW OF VACCINES, 2006, 5 (04) : 445 - 459
  • [10] Meningococcal vaccine groups A C Y W-135 conjugateGuillain Barre syndrome: case report
    [J]. Reactions Weekly, 2007, 1135 (1) : 22 - 22
12345